CLINICAL_TRIALS
trial_result
· 2013-11-15
Clinical Trial Update: Study Evaluating Bapineuzumab In Alzheimer Disease Subjects [Phase 2]
Summary
Pfizer completed a Phase 2 study evaluating bapineuzumab in Alzheimer's disease. Results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-11-15